William Blair analyst Tim Lugo is downgrading CoLucid (NASDAQ:CLCD) following the announcement of the firm’s pending acquisition by Eli Lilly and Co (NYSE:LLY), …
CoLucid Pharmaceuticals Inc CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) shares are on the run today after the migraine-medicine maker announced a definitive merger agreement with Eli …
CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) shares are trading up 32% in Wednesday’s trading session after announcing an agreement for healthcare giant Eli Lilly (NYSE:LLY) …
CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) saw it’s shares jumping over 30% in pre-market trading after announcing a definitive merger agreement with Eli Lilly. Under …
